Yanhua Xu

301 Middle Yanchang Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target.

Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target.

Journal: Cell reports

Published: May 19, 2026

Advancements and insights into newborn screening with tandem mass spectrometry in China: a comprehensive descriptive analysis (2017-2021).

Advancements and insights into newborn screening with tandem mass spectrometry in China: a comprehensive descriptive analysis (2017-2021).

Journal: BMJ paediatrics open

Published: December 13, 2025

Aging mechanisms and rejuvenation strategies for hematopoietic stem cells.

Aging mechanisms and rejuvenation strategies for hematopoietic stem cells.

Journal: Genome biology

Published: November 24, 2025

Newborn screening, genetic analysis, and long-term follow-up of 89 cases with short-chain acyl-CoA dehydrogenase deficiency (SCADD).

Newborn screening, genetic analysis, and long-term follow-up of 89 cases with short-chain acyl-CoA dehydrogenase deficiency (SCADD).

Journal: Molecular genetics and metabolism reports

Published: October 31, 2025

The expression and mechanism of action of ADAMTS18 in endometrial cancer.

The expression and mechanism of action of ADAMTS18 in endometrial cancer.

Journal: Journal of molecular histology

Published: September 11, 2025

Barriers and Enablers of Electronic Health Literacy in Colorectal Cancer Patients: A Phenomenological Study.

Barriers and Enablers of Electronic Health Literacy in Colorectal Cancer Patients: A Phenomenological Study.

Journal: Patient preference and adherence

Published: August 19, 2025

Bidirectional 2-sample Mendelian randomization study of the causal relationship between hypothyroidism and cardiovascular diseases.

Bidirectional 2-sample Mendelian randomization study of the causal relationship between hypothyroidism and cardiovascular diseases.

Journal: Medicine

Published: May 18, 2025

Low-dose lenvatinib plus toripalimab for patients with platinum-resistant recurrent ovarian cancer: preliminary results from a multicenter, phase II trial (NCT06241105).

Low-dose lenvatinib plus toripalimab for patients with platinum-resistant recurrent ovarian cancer: preliminary results from a multicenter, phase II trial (NCT06241105).

Journal: Gynecologic oncology

Published: May 16, 2025

A single-centre retrospective study on the clinical characteristics of patients with hereditary angioedema and the therapeutic effect of lanadelumab.

A single-centre retrospective study on the clinical characteristics of patients with hereditary angioedema and the therapeutic effect of lanadelumab.

Journal: Orphanet journal of rare diseases

Published: February 24, 2025

PRL2 negatively regulates FcεRI mediated activation of mast cells.

PRL2 negatively regulates FcεRI mediated activation of mast cells.

Journal: Cell death & disease

Published: January 11, 2025

A longitudinal study of resilience and social function in patients with colorectal cancer and stomas.

A longitudinal study of resilience and social function in patients with colorectal cancer and stomas.

Journal: Journal of psychosomatic research

Published: November 08, 2024

Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial.

Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial.

Journal: International journal of women's health

Published: October 24, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026